Compounds > 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone
Page last updated: 2024-08-24

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Breast Cancer

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aisner, J; Budman, DR; Forastiere, A; Perloff, M; Perry, M; Weinberg, V; Wood, W1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Breast Cancer

ArticleYear
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
    Cancer treatment reports, 1982, Volume: 66, Issue:10

    Topics: Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Breast Neoplasms; Cyclohexenes; Drug Evaluation; Female; Humans; Leukocyte Count; Middle Aged

1982